查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614054

药物和器械组合产品市场：按产品、应用和最终用户划分 - 全球预测 2025-2030

Drug-Device Combination Products Market by Product (Antimicrobial Catheters, Drug Eluting Stents, Infusion Pumps), Application (Antimicrobial Application, Cancer Treatment, Cardiovascular Disorder), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年药品器材组合产品市值为1,339.5亿美元，预计2024年将达到1,445.9亿美元，复合年增长率为8.09%，到2030年将达到2,310.5亿美元，预计将达到1000万美元。

药械组合产品是将药物和医疗设备结合起来以提高治疗能力的治疗和诊断干预措施。这些产品旨在透过促进精确的药物输送来改善患者的治疗效果，例如将药物直接输送到肺部的药物释放型支架和吸入器。对这些产品的需求源于它们提供标靶治疗、最大限度地减少副作用并提高患者用药依从性的能力。这些产品在心臟病学、肿瘤学和糖尿病管理等各个领域都有广泛的应用，主要用于医院、诊所和居家医疗。关键的市场成长要素包括慢性病和文明病疾病的增加、生物技术和材料科学的进步以及对个人化医疗的日益重视。全球人口老化和促进创新的法律规范进一步推动需求。值得注意的是，製药和医疗设备公司之间合併和联盟的增加为加速产品开发提供了机会。

主要市场统计
基准年[2023] 1339.5亿美元
预测年份 [2024] 1445.9亿美元
预测年份 [2030] 2310.5亿美元
复合年增长率（%） 8.09%

然而，市场面临一些限制，例如高昂的研发成本可能会限制新参与企业的进入，以及严格的监管要求可能会延迟上市时间。智慧财产权问题和大规模临床试验的需求也带来了挑战。儘管存在这些障碍，先进材料和智慧技术的开发仍然存在潜在机会，例如基于即时生理监测释放药物的可穿戴设备。鼓励创新者专注于改善药品和设备之间的接口，使它们更易于使用并适应不同的医疗保健场景。该市场充满活力，其特点是快速的技术创新和竞争压力，为能够预测和适应医疗保健服务新趋势的创新参与者创造了成熟的环境。

市场动态：针对快速发展的药物器材组合产品市场所揭示的关键市场见解

供需的动态交互作用正在改变药品器材组合产品市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病流行和强调标靶治疗
    • 政府对各种药物和器械组合产品的有利核准
    • 偏好微创手术以及使用抗菌药物和药物释放型支架
  • 市场限制因素
    • 药物器械组合产品的剂量和操作限制
  • 市场机会
    • 药械组合产品技术进步
    • 扩大药物器材组合产品商业化的合併策略
  • 市场挑战
    • 与定製组合药物核准相关的监管障碍

波特五力：驾驭药物器械组合产品市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物器材组合产品市场的外部影响

外部宏观环境因素在塑造药品器材组合产品市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解药物和器材组合产品市场的竞争状况

对药物和器械组合产品市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵药物器材组合产品市场供应商的绩效评估

FPNV定位矩阵是评估药物和器械组合产品市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议 规划药物和器材组合产品市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，药物器材组合产品市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病盛行率与标靶治疗的重点
      • 对各种药物和器械组合产品的有利政府核准
      • 优先考虑微创手术以及使用抗菌和药物释放型支架
    • 抑制因素
      • 药物器械组合产品的剂量和操作限制
    • 机会
      • 药械组合产品技术进步
      • 扩大药品和医疗设备组合产品商业化的合併策略
    • 任务
      • 与客製化组合产品核准相关的监管障碍
  • 市场区隔分析
    • 产品：在外科手术中增加药物释放型支架和整形外科复合材料产品的使用
    • 应用：有效治疗肿瘤和心血管疾病的药物器材组合产品的新兴需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药品器材组合产品市场：副产品

  • 抗菌导管
  • 药物释放型支架
  • 点滴帮浦
  • 吸入器
  • 整形外科复合产品
  • 光动力动态仪
  • 预填充式注射器
  • 经皮吸收贴片
  • 创伤护理产品

第七章 药品器材组合产品市场：依应用分类

  • 抗菌应用
  • 癌症治疗
  • 心血管疾病
  • 糖尿病
  • 呼吸系统问题

第八章药物器械组合产品市场：依最终用户分类

  • 门诊手术中心
  • 家庭护理设置
  • 医院/诊所

第九章美洲药物和器械组合产品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太药物与器材组合产品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲/中东/非洲药品器材组合产品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Nemera 与 Nelson Lab Europe 加强合作伙伴关係，为客户提供全面服务
    • Kindeva 和 Meridian 合併创建领先的製药和医疗设备组合产品 CDMO
    • Terumo Corporation宣布推出与 Kyowa Kirin 共同开发的药品/医疗设备组合产品
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cardinal Health, Inc.
  • CODAN Companies
  • Cook Group Incorporated
  • F. Hoffmann-La Roche AG
  • Fresenius Kabi
  • ICU Medical, Inc.
  • InfuTronix
  • InSitu Technologies Inc.
  • Insulet Corporation
  • JMS North America Corporation
  • Lepu Medical Technology Company
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Novartis AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • SOOIL Developments Co., Ltd.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Viatris Inc.
  • WL Gore & Associates Inc.
  • Zyno Medical
Product Code: MRR-742BD517D8D5

The Drug-Device Combination Products Market was valued at USD 133.95 billion in 2023, expected to reach USD 144.59 billion in 2024, and is projected to grow at a CAGR of 8.09%, to USD 231.05 billion by 2030.

Drug-device combination products are therapeutic and diagnostic interventions that integrate drugs with medical devices, offering enhanced treatment capabilities. They are designed to improve patient outcomes by facilitating precise drug delivery, such as in the use of drug-eluting stents or inhalers that deliver medication directly to the lungs. The necessity of these products stems from their ability to offer targeted therapy, minimize side effects, and increase patient adherence to medication regimes. They have broad applications across various domains, including cardiology, oncology, and diabetes management, and are predominantly used in hospital settings, clinics, and home healthcare. Key market growth factors include the increasing prevalence of chronic and lifestyle-related diseases, advances in biotechnology and materials science, and a growing emphasis on personalized medicine. An aging global population and regulatory frameworks that promote innovation drive demand further. Notably, increasing mergers and collaborations among pharmaceutical and medical device companies present opportunities to expedite product development.

KEY MARKET STATISTICS
Base Year [2023] USD 133.95 billion
Estimated Year [2024] USD 144.59 billion
Forecast Year [2030] USD 231.05 billion
CAGR (%) 8.09%

However, the market faces limitations such as stringent regulatory requirements that can delay time to market, alongside high research and development costs which may limit entry for new players. Intellectual property issues and the need for extensive clinical trials also pose challenges. Despite these obstacles, potential opportunities lie in the development of advanced materials and smart technologies, like wearable devices that release medication based on real-time physiological monitoring. Innovators are encouraged to focus on improving the interface between drugs and devices, making them more user-friendly and adaptable across various healthcare scenarios. The market is highly dynamic, characterized by rapid technological innovation and competitive pressures, creating an environment ripe for innovative players who can anticipate and adapt to emerging trends in healthcare delivery.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug-Device Combination Products Market

The Drug-Device Combination Products Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of chronic disease and emphasis on targeted treatments
    • Favorable government approvals for various drug-device combination products
    • Preference for minimally invasive surgeries and use of antimicrobial and drug-eluting stents
  • Market Restraints
    • Dosing and operational limitations of drug-device combination products
  • Market Opportunities
    • Technological advancements in drug-device combination products
    • Amalgamation strategies to expand drug-device combination product commercialization
  • Market Challenges
    • Regulatory hurdles associated with approval of customized combination products

Porter's Five Forces: A Strategic Tool for Navigating the Drug-Device Combination Products Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug-Device Combination Products Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug-Device Combination Products Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug-Device Combination Products Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug-Device Combination Products Market

A detailed market share analysis in the Drug-Device Combination Products Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug-Device Combination Products Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug-Device Combination Products Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug-Device Combination Products Market

A strategic analysis of the Drug-Device Combination Products Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug-Device Combination Products Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Braile Biomedica, Cardinal Health, Inc., CODAN Companies, Cook Group Incorporated, F. Hoffmann-La Roche AG, Fresenius Kabi, ICU Medical, Inc., InfuTronix, InSitu Technologies Inc., Insulet Corporation, JMS North America Corporation, Lepu Medical Technology Company, Medtronic PLC, MicroPort Scientific Corporation, Novartis AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., SOOIL Developments Co., Ltd., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Viatris Inc., W. L. Gore & Associates Inc., and Zyno Medical.

Market Segmentation & Coverage

This research report categorizes the Drug-Device Combination Products Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Antimicrobial Catheters, Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Photodynamic Therapy Devices, Prefilled Syringes, Transdermal Patches, and Wound Care Products.
  • Based on Application, market is studied across Antimicrobial Application, Cancer Treatment, Cardiovascular Disorder, Diabetes, and Respiratory Problem.
  • Based on End-user, market is studied across Ambulatory Surgery Centers, Home Care Settings, and Hospital & Clinic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic disease and emphasis on targeted treatments
      • 5.1.1.2. Favorable government approvals for various drug-device combination products
      • 5.1.1.3. Preference for minimally invasive surgeries and use of antimicrobial and drug-eluting stents
    • 5.1.2. Restraints
      • 5.1.2.1. Dosing and operational limitations of drug-device combination products
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in drug-device combination products
      • 5.1.3.2. Amalgamation strategies to expand drug-device combination product commercialization
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles associated with approval of customized combination products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing use of drug eluting stents and orthopedic combination products in surgical procedures
    • 5.2.2. Application: Emerging need of drug-device combination products for efficient treatment across oncology and cardiovascular disorder
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug-Device Combination Products Market, by Product

  • 6.1. Introduction
  • 6.2. Antimicrobial Catheters
  • 6.3. Drug Eluting Stents
  • 6.4. Infusion Pumps
  • 6.5. Inhalers
  • 6.6. Orthopedic Combination Products
  • 6.7. Photodynamic Therapy Devices
  • 6.8. Prefilled Syringes
  • 6.9. Transdermal Patches
  • 6.10. Wound Care Products

7. Drug-Device Combination Products Market, by Application

  • 7.1. Introduction
  • 7.2. Antimicrobial Application
  • 7.3. Cancer Treatment
  • 7.4. Cardiovascular Disorder
  • 7.5. Diabetes
  • 7.6. Respiratory Problem

8. Drug-Device Combination Products Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Home Care Settings
  • 8.4. Hospital & Clinic

9. Americas Drug-Device Combination Products Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug-Device Combination Products Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug-Device Combination Products Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Nemera and Nelson Labs Europe trengthen partnership to offer integrated services to customer
    • 12.3.2. Kindeva and Meridian Combine: Create Leading Drug-Device Combination Product CDMO
    • 12.3.3. Terumo Announces Launch of Drug-Device Combination Product Co-Developed with Kyowa Kirin
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. B. Braun SE
  • 3. Baxter International Inc.
  • 4. Becton, Dickinson and Company
  • 5. BIOTRONIK SE & Co. KG
  • 6. Boston Scientific Corporation
  • 7. Braile Biomedica
  • 8. Cardinal Health, Inc.
  • 9. CODAN Companies
  • 10. Cook Group Incorporated
  • 11. F. Hoffmann-La Roche AG
  • 12. Fresenius Kabi
  • 13. ICU Medical, Inc.
  • 14. InfuTronix
  • 15. InSitu Technologies Inc.
  • 16. Insulet Corporation
  • 17. JMS North America Corporation
  • 18. Lepu Medical Technology Company
  • 19. Medtronic PLC
  • 20. MicroPort Scientific Corporation
  • 21. Novartis AG
  • 22. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 23. SOOIL Developments Co., Ltd.
  • 24. Stryker Corporation
  • 25. Teleflex Incorporated
  • 26. Terumo Corporation
  • 27. Viatris Inc.
  • 28. W. L. Gore & Associates Inc.
  • 29. Zyno Medical

LIST OF FIGURES

  • FIGURE 1. DRUG-DEVICE COMBINATION PRODUCTS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG-DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DRUG-DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG-DEVICE COMBINATION PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG-DEVICE COMBINATION PRODUCTS MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ORTHOPEDIC COMBINATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PHOTODYNAMIC THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY WOUND CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY ANTIMICROBIAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY CARDIOVASCULAR DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY RESPIRATORY PROBLEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY HOSPITAL & CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. MALAYSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. PHILIPPINES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. SINGAPORE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. SOUTH KOREA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. TAIWAN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. THAILAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. VIETNAM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. DENMARK DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. EGYPT DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. FINLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. FRANCE DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. GERMANY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. ISRAEL DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. ITALY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NETHERLANDS DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. NIGERIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. NORWAY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. POLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. QATAR DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. RUSSIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SAUDI ARABIA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH AFRICA DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SPAIN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. SWEDEN DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. SWITZERLAND DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. TURKEY DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED ARAB EMIRATES DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM DRUG-DEVICE COMBINATION PRODUCTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. DRUG-DEVICE COMBINATION PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 155. DRUG-DEVICE COMBINATION PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2023